BOSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS) provided an update on the abaloparatide transdermal system (abalo-TDS) development program. As ...
Pain, both acute and chronic, is a common complaint that must be managed by health care professionals of varying specialties. The assessment and treatment of pain, deemed “the fifth vital sign” by the ...
Transdermal drug delivery is valued by patients and physicians for the comfort and convenience it offers — no needles, no pills and ease of use Transdermal drug delivery is valued by patients and ...
The U.S. Food and Drug Administration announced last week that a pharmaceutical company is removing a fentanyl patch from ...
The approval granted by the US Food and Drug Administration (USFDA) is to market the Scopolamine transdermal system of dosage 1 mg/3 days, Zydus Lifesciences said in a regulatory filing. New Delhi: ...
The FDA has approved MediBeacon®'s TGFR system for noninvasive kidney function assessment, targeting both normal and impaired renal patients. INNOVATE Corp. announced the FDA approval of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback